Search

everythinglearnresearchcommunity

for

Search:↓

Vertex pattern hair loss linked to higher prostate cancer risk.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Hair can be used to measure cancer-related chemicals noninvasively.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Finasteride does not prevent bladder cancer.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Using certain hair products may increase breast cancer risk in black women.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.